Ling Li

21.7k citations
540 papers · 14.5k indexed · 5 hit papers · h-index 58

Ling Li

516 papers receiving 14.3k citations

Hit Papers

3D-bioprinted B...1392001202620092017100200300400500

Peers

Ling Li
Comparison fields: 5 of 173
  • Cancer Research 2.3k
  • Molecular Biology 7.0k
  • Endocrine and Autonomic Systems 567
  • Endocrinology, Diabetes and Metabolism 1.3k
  • Physiology 2.0k
Replace Yan Chen with:
Yan Chen China
Chih‐Yang Huang Taiwan
Makoto Suematsu Japan
Xiaokun Li China
Yan Li China
Athanasios G. Papavassiliou Greece
Yang Yang China
Osamu Ogawa Japan
Emanuela Mazzon Italy
Shinya Toyokuni Japan
Ling Li relative to Yan Chen China Yan Chen's profile →
Citations per field
00.5×1.5×
Yan Chen · 1×
Citations per year

Countries citing papers authored by Ling Li

Since Specialization
Citations

This map shows the geographic impact of Ling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Li more than expected).

Fields of papers citing papers by Ling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Li. The network helps show where Ling Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ling Li Line = papers co-authored together Ling Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20246
4 20242
5 20242
6 20240
7 20245
8 20243
9 20237
10 20236
11 202313
12 20234
13 202316
14 202234
15 202111
16 202015
17 201826
18 201872
19 201357
20 200854

About Ling Li

Ling Li is a scholar working on Cancer Research, Endocrine and Autonomic Systems, Molecular Biology, Endocrinology, Diabetes and Metabolism and Rheumatology, having authored 540 papers that have together received 14.5k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (50 papers), Adipokines, Inflammation, and Metabolic Diseases (49 papers), Metabolism, Diabetes, and Cancer (44 papers), Cancer-related molecular mechanisms research (32 papers), Liver Disease Diagnosis and Treatment (27 papers), Advanced biosensing and bioanalysis techniques (26 papers), Regulation of Appetite and Obesity (25 papers) and MicroRNA in disease regulation (24 papers). The work is most often cited by research in Cancer Research (2.3k citations), Molecular Biology (7.0k citations), Endocrine and Autonomic Systems (567 citations), Endocrinology, Diabetes and Metabolism (1.3k citations) and Physiology (2.0k citations). Ling Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Gangyi Yang, Mengliu Yang, Hua Liu, Guenther Boden, Bruce A. Edgar, Geneviève Renier, Leslie Saucedo, Xinsheng Gao, Harald Vaessin and Jingqiu Cheng. Their work appears in journals such as Scientific Reports, Oncotarget, Frontiers in Endocrinology, Diabetes and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026